PODCAST · health
OnCall
by Cencora
A podcast from Cencora where we discuss the latest industry information relevant to our GPO member practices. We will share regular updates from our knowledgeable staff and partners, as well as your respected peers, on everything from precision medicine and biosimilar innovations to practice management solutions and the legislative landscape. Listen from your computer during breaks at the office or from your phone on the go. OnCall will make it easy for you to access the education you want - whenever you want.
Episodes
-
Q2 2026 GPO Legislative Townhall
In this episode, we highlight a recent talk given by Joel White, Partner and Head of Health at Monument Advocacy. Topics in this episode include the Inflation Reduction Act negotiations, thoughts from Congress going into November midterms, and future next steps for legislation. If you have any...
-
Best Practices for Bispecifics
In this episode sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they talk about common challenges and…
more -
Implementing Bispecifics in a Clinical Practice
In this episode, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they talk about how to implement bispecifics in a clinical...
-
Operationalizing Bispecifics in Practice
In this episode, sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they talk about how to implement...
-
The Basics of Bispecifics
In this episode sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they give an overview on the basics of...
-
Q1 2026 GPO Legislative Townhall
In this episode, we highlight a recent talk given by Joel White, Partner and Head of Health at Monument Advocacy. Topics in this episode include the 2026 legislative outlook, drug policy updates, market consolidation issues, and physician payment issues. If you have any other questions for our...
-
Operationalizing Radiopharmaceuticals in Your Practice
In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us a rundown on operationalizing radiopharmaceuticals in your practice. That is a wrap on our radiopharmaceutical series and we are...
-
Radiopharmaceuticals: Billing and Reimbursement
In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an overview on billing and reimbursement of radiopharmaceuticals. If you have any other questions for our guests, or suggestions for...
-
Radiopharmaceutical Landscape
In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an overview on the landscape surrounding radiopharmaceuticals. If you have any other questions for our guests, or suggestions for...
-
Introduction to Radiopharmaceuticals
In this episode, Cencora's Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an introduction to the basics of radiopharmaceuticals. If you have any other questions for our guests, or suggestions for...
-
Q4 2025 GPO Legislative Townhall
In this episode, Joel White, Partner and Head of Health at Monument Advocacy, talks about updates on DC legislative and regulatory issues, what to expect in 2026 for physician and hospital payments and the Rural Health fund, drug reimbursement and what to expect when IRA prices go live January 1,...
-
Q3 GPO Legislative Townhall
In this episode, Joel White, Partner and Head of Health Practice at Monument Advocacy, will discuss the Medicare physician fee schedule proposed rule and impact on practices and manufacturers, end of the year health priorities for congress, and Trump Administration goals, plans and efforts on…
more -
Inflation Reduction Act: Current State
In this episode, Whitley Quan, Manager of Cencora's U.S. Public Policy will be speaking on the current state of IRA implementation and what Cencora is doing to help its customer prepare for IRA deadlines. For IRA specific questions, please reach out to [email protected]. If you have any…
more -
Q2 GPO Legislative Townhall
In this episode, Joel White, President and CEO of Horizon Government Affairs will be speaking on budget bill and payment updates for physicians, CMMI reforms for value-based care, CMS focus on technology assisted care, and drug price reforms. If you have questions for our guests, or suggestions…
more -
Inflation Reduction Act: Overview
In this episode, the first of our new Inflation Reduction Act series, Cencora's VP of Market Economics, Tyler Novotny, and Megan Law, Sr. Director of Specialty GPO Portfolio Accounts, will give an overview of IRA and dive into IRA impact on patients, manufacturers, and providers. If you have...
-
505(b)(2) Operationalizing in Practice - Provider Perspective
In this episode, the final of our 505(b)(2) series, sponsored by Avyxa, we are joined by Dr. Fred Divers, Chief Medical Officer for American Oncology Network, and Dr. Ralph Boccia, hematologist oncologist, member of American Oncology Network, and the International Oncology Network's Chief Medical...
-
505(b)(2) Operationalizing in Practice - Pharmacist Perspective
In this episode, the fourth of our 505(b)(2) series, sponsored by Avyxa, we are joined by James Gilmore, Chief Pharmacy and Clinical Services Officer at American Oncology Network, and Joe Shupp, VP of Sales for Cencora's ION Oncology Network, who will discuss operationalizing in practice from a...
-
505(b)(2) Billing and Reimbursement
In this episode, the third of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Trey McNiel, Senior Director of Sales for Cencora's...
-
505(b)(2) Landscape and Pipeline
In this episode, the second of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Matthew Letow, Senior Director of Sales New…
more -
505(b)(2) Basics
In this episode, the first of our 505(b)(2) series, sponsored by Avyxa, we are joined by Zach Horstman, Director of Specialty GPO Corporate Accounts for Cencora, and Yoni Resnick, Director of Pharmacy Clinical Services at New England Cancer Specialists, who will discuss the basics of 505(b)(2)s.…
more -
Buy and Bill: Practice Perspective
In this episode, we are joined by Cencora's Specialty Practice Network National Senior Director of Sales for Immunology, Chara Reid, VP Sales for Cencora's Specialty Practice Network, Kortney Cooper, and Elizabeth Johnson, CEO of MedicoCX, who will discuss how buy and bill is implemented in...
-
Buy and Bill: The Basics
In this episode, we are joined by Kortney Cooper, VP of Sales for Cencora's Specialty Practice Network, who will discuss the basics of buy and bill. To find a copy of Kortney's presentation, please visit our OnCall page under Clinical Education on our ION and Specialty Practice Network websites.…
more -
GPO 101: Legislative Townhall
In this episode, we are joined by Joel White, President of Horizon Government Affairs, who will discuss the Inflation Reduction Act, PBM reform, drug shortages, Medicare physician payment and telehealth issues. If you have questions for our guests or suggestions for future topics, send us an…
more -
Biosimilar Basics: Payer Perspective
In this episode, the fourth of our Biosimilars series, Christie Smith discusses the biosimilar payer perspective. If you have any questions for our guests or have a topic you would like to learn more about, email us at [email protected].
-
Biosimilar Basics: Legislation
In this episode, the third of our Biosimilars series, Corey Ford, Vice President of Reimbursement and Policy Insights, and Cristina Muñoz, Senior Director of Head of State Government Advocacy discuss legislation surrounding biosimilars. Our next episode will feature information on the biosimilar...
-
Biosimilar Basics: Market Landscape
In this episode, the second of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss the current Biosimilar landscape and what we can expect to see in the market. Our next episode will feature information...
-
Biosimilar Basics: Overview
In this episode, the first of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss Biosimilars 101 and resources to utilize to stay better informed. Our next episode will feature information on the…
more -
GPO Legislative Townhall December 2023: Part 11
In this episode, the eleventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses drug pricing and shortages. If you have any questions for our guests or have a topic you would like to learn more about, email us at [email protected].
-
GPO Legislative Townhall December 2023: Part 10
In this episode, the tenth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses transparency in the House, competition, and lower costs on drugs and services. Our next episode will feature information on drug pricing and shortages. If you…
more -
GPO Legislative Townhall December 2023: Part 9
In this episode, the ninth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses health issues around Medicare physician payment, and PBM reform. Our next episode will feature information on transparency in the House, competition, and lower...
-
GPO Legislative Townhall August 2023: Part 8
In this episode, the eighth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses MPFS, Medicare Drug Price Negotiations, PBM reform, and elections. That's all for this episode of OnCall. Our next episode will feature information on politics...
-
GPO Legislative Townhall August 2023: Part 7
In this episode, the seventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses Congress and the fiscal backdrop. Our next episode will feature information on issues regarding MPFS, Medicare Drug Price Negotiations, PBM reform, and...
-
GPO Legislative Townhall May 2023: Part 6
In this episode, the sixth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the new DEA proposed rules on prescribing controlled substances and treatments. Our next episode will feature information on payment updates for Medicare. If you...
-
GPO Legislative Townhall May 2023: Part 5
In this episode, the fifth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the End of the Public Health Emergency and what it means for practices. Our next episode will feature information on the New DEA proposed rules on prescribing...
-
GPO Legislative Townhall May 2023: Part 4
In this episode, the fourth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses federal budget and debt negotiations and the implications for Medicare, Medicaid and ACA. Our next episode will feature information on the end of the Public...
-
GPO Legislative Townhall Feb 2023: Part 3
In this episode, the third of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss the Inflation Reduction Act, PBM reform, and 2023 regulations. Our next episode will feature information on federal budget and debt negotiations and...
-
GPO Legislative Townhall Feb 2023: Part 2
In this episode, the second of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss drug coverage, pricing, and payment. Our next episode will feature information on the Inflation Reduction Act, PBM reform, and 2023 regulations. If...
-
GPO Legislative Townhall Feb 2023: Part 1
In this episode, the first of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss three important policy trends impacting physicians: Medicare payments, drugs/biologics, and disparities/SDOH. Our next episode will feature…
more -
Operational Pathways for Biomarker Testing in NSCLC
In this Amgen sponsored podcast, David R. Braxton, MD, Chief of Service for Molecular Pathology at Hoag Hospital, shares his insights as considerations on operationalizing biomarker testing into clinical practice in NSCLC. He discusses considerations on improving the turnaround time of test...
-
Biosimilar Series: Part 5
In this episode, the fifth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about operationalizing biosimilars into practice and the differences and similarities of this process for biosimilars versus their counterparts. If you have any...
-
Biosimilar Series: Part 4
In this episode, the fourth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the role of the payer in relation to biosimilars, the formulary management process and the differences in treatment of biosimilars by Medicaid and…
more -
Biosimilar Series: Part 3
In this episode, the third of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the FDA approval process for biosimilars, the Biologics Price Competition and Innovation Act and safety issues or adverse effects related to biosimilar…
more -
Biosimilar Series: Part 2
In this episode, the second of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss the history of biosimilars, the reception of them in the medical community and their road ahead....
-
Biosimilar Series: Part 1
In this episode, the first of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss what biosimilars are (and aren’t), interchangeability with their reference products, and Kathy’s...
-
Biomarkers: Emerging Targets and Technologies
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the importance of emerging biomarkers to basket and umbrella trial...
-
Biomarker Testing: A Closer Look at When, Who, and How to Test
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the advantages and disadvantages of liquid biopsies to the benefits of...
-
Germline Genetic Testing
In this podcast series brought to you by Invitae, oncology specialists who routinely integrate genetic information into their patients' treatment, discuss actionable options for implementing genomics-informed, personalized cancer care. In the first installment of this series, Dr. Rakesh Patel,...
-
Buy and Bill 101: Part 4
In the final episode of our buy and bill series, we discuss reducing financial barriers for your patients and talk to Joe Baffone, CEO of Annexus Health, about the benefit of implementing efficient financial navigation programs within your practice. Visit our website for more information or to...
-
Buy and Bill 101: Part 3
In this episode, we talk about the reimbursement aspect of the buy and bill model and the four key issues that could negatively impact the health of your revenue cycle. Click here to get in touch with us for more information on this or variety of other topics related to your specialty practice.…
more -
Biomarkers 101: Basics of Biomarker Testing
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about the basics of biomarker testing – from identifying common testing approaches to comparing DNA and RNA sequencing. If you have any...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
A podcast from Cencora where we discuss the latest industry information relevant to our GPO member practices. We will share regular updates from our knowledgeable staff and partners, as well as your respected peers, on everything from precision medicine and biosimilar innovations to practice management solutions and the legislative landscape. Listen from your computer during breaks at the office or from your phone on the go. OnCall will make it easy for you to access the education you want - whenever you want.
HOSTED BY
Cencora
Loading similar podcasts...
Frequently Asked Questions
How many episodes does OnCall have?
OnCall currently has 62 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is OnCall about?
A podcast from Cencora where we discuss the latest industry information relevant to our GPO member practices. We will share regular updates from our knowledgeable staff and partners, as well as your respected peers, on everything from precision medicine and biosimilar innovations to practice...
How often does OnCall release new episodes?
OnCall has 62 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to OnCall?
You can listen to OnCall on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts OnCall?
OnCall is created and hosted by Cencora.
URL copied to clipboard!